Could excessive iron supplements in pregnancy increase risk of type-1 diabetes?

By Tim Cutcliffe contact

- Last updated on GMT

© iStock
© iStock

Related tags: Infant

Higher blood levels of iron in new-born babies were found to be associated with a higher likelihood of type-1 diabetes (T1D) before the age of 16, according to a recent study in Nutrients.

A doubling of iron content of the infants’ blood was linked to more than twice the risk of developing childhood T1D, discovered the research team led by Herlev University Hospital, Denmark.

The scientists also found that neonates’ blood iron content increased with maternal age and that baby girls had significantly higher levels of blood iron than boys.

“To our knowledge, this is the first study to investigate and demonstrate a positive association between neonatal iron content in blood and the risk of developing T1D before the age of 16 years. Furthermore, iron content was significantly lower in boys than in girls, and increased with maternal age,” ​wrote lead author Julie Nyholm Kyvsgaard.

“This association became even stronger after adjusting for possible confounders (sex, maternal age at delivery, birth weight, gestational age, and human leukocyte antigen (HLA) risk),”​ she added.


Iron deficiency and anaemia are common in pregnancy. Iron supplementation is frequently recommended to satisfy increased maternal demands during the term. However, a previous study​ had shown that 37% of Danish pregnant women consumed more than the recommended level of 50-70 milligrams/day (mg/d). The findings raise a concern that iron overload may possibly be involved with pancreatic beta-cell injury, although mechanisms for this are not established.

The study was of case-control design and involved 199 children diagnosed with T1D prior to age 16.    Iron was measured in the infants using a single dried blood spot sample.

Due to the observational nature of the study, no causality can be inferred.

The researchers also emphasised that other questions needed to be answered before any change to guidelines on iron supplementation could be considered.

 “Further research is obviously needed to prove causality,” ​wrote the researchers.

Further, causes of high neonatal iron such as genetic profile and correlation with maternal iron status needs further exploration before any change in guidelines should be made,”​ they added.



Source:    Nutrients

Volume 9, issue 11, article 1221.      DOI:   10.3390/nu9111221

“High Neonatal Blood Iron Content Is Associated with the Risk of Childhood Type 1 Diabetes Mellitus”

Authors:   Julie Nyholm Kyvsgaard, Jannet Svensson, et al


Related news

Show more

Related products

show more

DurOmega® Algal DHA 20% water dispersible powder

DurOmega® Algal DHA 20% water dispersible powder

INNOBIO Corporation Limited | 30-May-2022 | Technical / White Paper

INNOBIO most recently launched a new product DurOmega® Algal DHA 20% water dispersible powder with significantly reduced fishy odor and taste, which optimizes...

Total Solutions for Cognitive Health by Lubrizol

Total Solutions for Cognitive Health by Lubrizol

Lipofoods, a Lubrizol Company | 05-May-2022 | Technical / White Paper

Globally, health and wellbeing have shifted from a focus on physical health and nutrition to also include cognitive and mental wellness, therefore consumers...

Trending solutions for immunity beverages

Trending solutions for immunity beverages

Prinova Europe Limited | 12-Apr-2022 | Technical / White Paper

One of the effects of COVID-19 has been to increase consumer interest in beverages with functional benefits, particularly for immune health.

Alesco, the Sucrosomial® company

Alesco, the Sucrosomial® company

Alesco S.r.l. | 29-Mar-2022 | Product Brochure

Alesco raw materials and functional ingredients offer unique, scientifically proven characteristics, suited for a wide range of needs in the pharmaceutical,...

Related suppliers

Follow us


View more